Anti-NPNT/ EGFL6L/ POEM functional antibody

Anti-NPNT/ EGFL6L/ POEM functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to NPNT/NPNT products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0595-Ab-1/ GM-Tg-hg-SE0595-Ab-2Anti-Human NPNT monoclonal antibodyHuman
GM-Tg-rg-SE0595-Ab-1/ GM-Tg-rg-SE0595-Ab-2Anti-Rat NPNT monoclonal antibodyRat
GM-Tg-mg-SE0595-Ab-1/ GM-Tg-mg-SE0595-Ab-2Anti-Mouse NPNT monoclonal antibodyMouse
GM-Tg-cynog-SE0595-Ab-1/ GM-Tg-cynog-SE0595-Ab-2Anti-Cynomolgus/ Rhesus macaque NPNT monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0595-Ab-1/ GM-Tg-felg-SE0595-Ab-2Anti-Feline NPNT monoclonal antibodyFeline
GM-Tg-cang-SE0595-Ab-1/ GM-Tg-cang-SE0595-Ab-2Anti-Canine NPNT monoclonal antibodyCanine
GM-Tg-bovg-SE0595-Ab-1/ GM-Tg-bovg-SE0595-Ab-2Anti-Bovine NPNT monoclonal antibodyBovine
GM-Tg-equg-SE0595-Ab-1/ GM-Tg-equg-SE0595-Ab-2Anti-Equine NPNT monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0595-Ab-1/ GM-Tg-hg-SE0595-Ab-2; GM-Tg-rg-SE0595-Ab-1/ GM-Tg-rg-SE0595-Ab-2;
GM-Tg-mg-SE0595-Ab-1/ GM-Tg-mg-SE0595-Ab-2; GM-Tg-cynog-SE0595-Ab-1/ GM-Tg-cynog-SE0595-Ab-2;
GM-Tg-felg-SE0595-Ab-1/ GM-Tg-felg-SE0595-Ab-2; GM-Tg-cang-SE0595-Ab-1/ GM-Tg-cang-SE0595-Ab-2;
GM-Tg-bovg-SE0595-Ab-1/ GM-Tg-bovg-SE0595-Ab-2; GM-Tg-equg-SE0595-Ab-1/ GM-Tg-equg-SE0595-Ab-2
Products NameAnti-NPNT monoclonal antibody
Formatmab
Target NameNPNT
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-NPNT benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0595-Ag-1Recombinant multi-species NPNT/ EGFL6L/ POEM protein
    ORF Viral VectorpGMAAV000295house mouse Npnt AAV plasmid
    ORF Viral VectorvGMAAV000295house mouse Npnt AAV particle


    Target information

    Target IDGM-SE0595
    Target NameNPNT
    Gene ID255743,114249,686753,694470,487891,101091192,513362,100073038
    Gene Symbol and Synonyms1110009H02Rik,EGFL6L,Nctn,NPNT,POEM
    Uniprot AccessionQ6UXI9
    Uniprot Entry NameNPNT_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000168743
    Target ClassificationN/A

    The target: NPNT, gene name: NPNT, also named as EGFL6L, POEM. Predicted to enable integrin binding activity. Predicted to be involved in several processes, including cell-cell adhesion mediated by integrin; positive regulation of ERK1 and ERK2 cascade; and positive regulation of osteoblast differentiation. Predicted to act upstream of or within positive regulation of transforming growth factor beta receptor signaling pathway. Located in extracellular exosome. Part of collagen-containing extracellular matrix. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.